• Highly absorbent
• Broad spectrum antimicrobial against gram negative and gram positive bacteria
• Bacterial reduction up to 7 days
• Non-adherent to wound bed
• Protects against maceration
• Either side of dressing can be placed on the wound
• Primary or secondary dressing

ZeniFOAM Ag is indicated for the management of moderate to heavily exuding wounds, including:
• Pressure injuries
• Venous leg ulcers
• Diabetic foot ulcers
• Surgical wounds
• Donor sites
• Partial thickness burns
• Traumatic wounds (such as lacerations, abrasions, and skin tears)

ZeniFOAM-Ag is contraindicated for:
• Full-thickness (third-degree) burns
• Dry or necrotic wounds without exudate
• Patients with known hypersensitivity or allergy to polyurethane foam, silver, or any dressing component.

• Single patient use only. Do not reuse.
• This dressing does not replace systemic therapy or other infection management in clinically infected wounds.
• Do not use with oxidizing agents (e.g., hydrogen peroxide, hypochlorite solutions) which may degrade the dressing.
• ZeniFOAM-Ag is intended for short-term use and should not be used for durations longer than 28 days. Transient discoloration of the peri-wound skin and wound may occur. Frequent or prolonged use may result in permanent discoloration of the skin.
• Avoid contact with electrodes or conducive gels during electronic measures such as electrocardiogram (ECG) and electroencephalograms (EEG).
• Remove the dressing prior to MRI, radiation, x-ray, ultrasound, thermotherapy and microwave diathermy.

No known adverse effects/reactions

ZeniFOAM-Ag should be kept in the sealed packaging. Store at room temperature in a cool, dry place. Avoid direct sunlight and excessive humidity. Dispose of used dressing per institutional policy and local regulations for medical waste.

Ionic silver